| | |
N (%)
| | |
|---|
|
Characteristics
|
Overall
|
High rank PCP
|
Low rank PCP
|
p-value
|
|---|
|
Overall
|
46782 (100)
|
22853 (100)
|
23929 (100)
| |
|
Any PSA testing
|
32697 (69.9)
|
18889 (82.7)
|
13808 (57.7)
|
<0.001
|
|
Any PSA testing ordered by patient’s PCP
|
24378 (52.1)
|
16403 (71.8)
|
7975 (33.3)
|
<0.001
|
|
Any PSA testing ordered by provider other than patient’s PCP
|
13649 (29.2)
|
5810 (25.4)
|
7839 (32.8)
|
<0.001
|
|
Age Years)
|
|
75–79
|
22024 (47.1)
|
10900 (47.7)
|
11124 (46.5)
|
0.008
|
|
80–84
|
14958 (32.0)
|
7287 (31.9)
|
7671 (32.1)
| |
|
≥ 85
|
9800 (20.9)
|
4666 (20.4)
|
5134 (21.5)
| |
|
Ethnicity
|
|
Non-Hispanic White
|
38169 (81.6)
|
18673 (81.7)
|
19496 (81.5)
|
<0.001
|
|
Black
|
1346 (2.9)
|
586 (2.6)
|
760 (3.2)
| |
|
Hispanic
|
6614 (14.1)
|
3209 (14.0)
|
3405 (14.2)
| |
|
Others
|
653 (1.4)
|
385 (1.7)
|
268 (1.1)
| |
|
Elixhauser Comorbidity
|
|
0
|
6110 (13.1)
|
2896 (12.7)
|
3214 (13.4)
|
0.027
|
|
1
|
12846 (27.5)
|
6230 (27.3)
|
6616 (27.6)
| |
|
2
|
11988 (25.6)
|
5889 (25.8)
|
6099 (25.5)
| |
|
3
|
7098 (15.2)
|
3559 (15.6)
|
3539 (14.8)
| |
|
≥ 4
|
8740 (18.7)
|
4279 (18.7)
|
4461 (18.6)
| |
|
Medicaid Eligible
|
|
Yes
|
4813 (10.3)
|
2328 (10.2)
|
2485 (10.4)
|
0.481
|
|
No
|
41969 (89.7)
|
20525 (89.8)
|
21444 (89.6)
| |
|
Urban/Rural
|
|
Metro
|
34536 (73.8)
|
17847 (78.1)
|
16689 (69.7)
|
<0.001*
|
|
Non-Metro
|
11279 (24.1)
|
4730 (20.7)
|
6549 (27.4)
| |
|
Rural
|
960 (2.1)
|
272 (1.2)
|
688 (2.9)
| |
|
Unknown
|
7 (0.0)
|
4 (0.0)
|
3 (0.0)
| |
|
Percent of persons in zip code 25 or older with high school education or higher
|
|
Q1: ≤ 74 %
|
11859 (25.3)
|
5514 (24.1)
|
6345 (26.5)
|
<0.001*
|
|
Q2: 74–83 %
|
11503 (24.6)
|
5009 (21.9)
|
6494 (27.1)
| |
|
Q3: 83–90 %
|
11815 (25.3)
|
5829 (25.5)
|
5986 (25.0)
| |
|
Q4: 90–100 %
|
11529 (24.6)
|
6485 (28.4)
|
5044 (21.1)
| |
|
Unknown
|
76 (0.2)
|
16 (0.1)
|
60 (0.3)
| |
- PCP primary care provider, PSA prostate specific antigen
- Q1 quartile 1, Q2 quartile 2, Q3 quartile 3, Q4 quartile 4
- p-value was calculated using chi-square test between high- and low-PSA-rate PCP groups
- *The unknown was excluded for chi-square test
